Solos Endoscopy, Inc. Receives Purchase Order from the National Cancer...( BOSTON Sept. 17 /- Solos Endosc...),Health

BOSTON, Sept. 17 /PRNewswire-FirstCall/ -- Solos Endoscopy, Inc. (Pink Sheets: SNDY) is pleased to announce that the Company has received multiple purchase orders for its MammoView(TM) line of surgical endoscopy instruments from the National Cancer Institute (NCI), Bethesda MD. NCI is 1 of 27 Institutes and Centers that comprise the U.S. National Institutes of Health (NIH), which is part of the U.S. Department of Health and Human Services.

NCI has built a national network that includes regional and community cancer centers, physicians who are cancer specialists, cooperative groups of clinical researchers, and volunteer and community outreach groups throughout the U.S. and works closely with similar institutions worldwide.

Solos Endoscopy's MammoView(TM) system employs advanced micro endoscopes and optical technology to give physicians sharp, clear images of the milk ducts where the majority of breast cancers arise.

"We are very pleased to be supplying our MammoView(TM) system top cancer care and research organization in the world. We believe that our system will get well deserved exposure through the infrastructure NCI provides for basic, translational and clinical research activities encompassing all aspects of cancer, including biology, genetics, epidemiology, detection, diagnosis, treatment, prevention, palliative care and survivorship," stated Bob Segersten, President of Solos Endoscopy, Inc.

For more information on the National Cancer Institute, please visit: